How to Treat Stage D Heart Failure? : When to Implant Left Ventricular Assist Devices in the Era of Continuous Flow Pumps?
スポンサーリンク
概要
- 論文の詳細を見る
The new classification of heart failure in the American College of Cardiology/American Heart Association guidelines includes stage D, which is refractory severe heart failure that does not respond to medical or resynchronization therapy. Among the many treatment strategies for stage D heart failure, only heart transplantation and ventricular assist devices have been established as improving prognosis. With the evolution in the mechanics of ventricular assist devices in recent years, the postoperative prognosis has improved, and less sick patients can now be candidates for these devices. In Japan, 2 continuous flow devices have been approved since April 2011, and now is the best time to consider the indications for their use. (Circ J 2011; 75: 2038-2045)
- 社団法人 日本循環器学会の論文
- 2011-08-25
著者
-
Kinugawa Koichiro
Department Of Cardiovascular Medicine Graduate School Of Medicine University Of Tokyo
-
Kinugawa Koichiro
Department Of Cardiovascular Medicine University Of Tokyo
関連論文
- Upregulated Neurohumoral Factors are Associated With Left Ventricular Remodeling and Poor Prognosis in Rats With Monocrotaline-Induced Pulmonary Arterial Hypertension
- Signaling Pathways Responsible for Fetal Gene Expression in the Failing Human Heart- Evidence for Altered Thyroid Hormone Receptor Gene Expression
- Dominant Negative Mutants of Transcriptional Factor AP-1 Dissociates Cardiac Myocyte Hypertrophy and Pathologic Gene Program
- Inhibition of Histone Deacetylase Reverses Repression of Myocyte-Specific Gene Expression Associated with Cardiac Hypertrophy
- IS011 Evolutionally-conserved role of nuclear factor-κB in expression of inducible nitric oxide synthase gene in ventricular myocytes
- PE-513 Three Dimensional Echocardiography Provides New Indexes for the Evaluation of Pulmonary Hypertension(PE086,Pulmonary Circulation (H),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
- PE-505 Resistance Training Combined with Aerobic One Effectively Improves Exercise Capacity in Patients Implanted with TOYOBO LVAS(PE085,Exercise Test/Cardiac Rehabilitation (H),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese C
- PE-244 Less Frequency of Native Aortic Valve Opening Causes Aortic Regurgitation in Patients with Left Ventricular Assist Device (LVAD)(PE041,Transplantation/LVAD (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation
- PE-241 Preoperative Clinical Profiles Predict Prognosis after Left Ventricular Assist Device Implantation(PE041,Transplantation/LVAD (M),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- Imatinib Mesylate Has The Potential to Exert Its Efficacy by Down-Regulating The Plasma Concentration of Platelet-Derived Growth Factor in Patients With Pulmonary Arterial Hypertension
- OE-054 Quality of Life Provides Additional Prognostic Information in Heart Failure Outpatients : A Two-year Follow-up Study(OE09,Heart Failure (Treatment) 1 (M),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Soc
- OJ-034 The More Spherical Right Ventricle and Less Spherical Left Ventricle in Patients with Severe Pulmonary Hypertension Assessed by Three-Dimensional Echocardiography(Echo/Doppler(03)(I),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of
- Age and Preoperative Total Bilirubin Level Can Stratify Prognosis After Extracorporeal Pulsatile Left Ventricular Assist Device Implantation
- Initial and Programmed Combination Therapy With Oral Drugs for Severe Idiopathic Pulmonary Arterial Hypertension
- Acute Effect of Sildenafil Is Maintained in Pulmonary Arterial Hypertension Patients Chronically Treated With Bosentan
- Less Frequent Opening of the Aortic Valve and a Continuous Flow Pump Are Risk Factors for Postoperative Onset of Aortic Insufficiency in Patients With a Left Ventricular Assist Device
- Quality of Life as an Independent Predictor for Cardiac Events and Death in Patients With Heart Failure
- How to Treat Stage D Heart Failure? : When to Implant Left Ventricular Assist Devices in the Era of Continuous Flow Pumps?
- Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangrene
- Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis : a preliminary report of three cases
- Novel Risk Scoring System With Preoperative Objective Parameters Gives a Good Prediction of 1-Year Mortality in Patients With a Left Ventricular Assist Device
- Intrathoracic Impedance Monitoring in Patients With Heart Failure
- A case of late-onset right ventricular failure after implantation of a continuous-flow left ventricular assist device
- Preliminary Report of Tolvaptan Treatment in Japanese Patients With Heart Failure
- Volumetric and Functional Assessment of Ventricles in Pulmonary Hypertension on 3-Dimensional Echocardiography
- Novel Criteria of Urine Osmolality Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
- Successful Conversion to Everolimus After Cytomegalovirus Infection in a Heart Transplant Recipient
- Trend of Clinical Outcome and Surrogate Markers During Titration of β-Blocker in Heart Failure Patients With Reduced Ejection Fraction : – Relevance of Achieved Heart Rate and β-Blocker Dose –
- Preoperative Levels of Bilirubin or Creatinine Adjusted by Age Can Predict Their Reversibility After Implantation of Left Ventricular Assist Device
- Rapidly Progressive Cardiac Allograft Vasculopathy in Early Onset Regressed With Everolimus Treatment in an Adult Cardiac Recipient
- Correction of Hyponatremia by Tolvaptan Before Left Ventricular Assist Device Implantation
- Intrathoracic Impedance Monitoring in Patients With Heart Failure : Correlation With Dehydration and Bleeding Events
- Early decision for a left ventricular assist device implantation is necessary for patients with modifier A
- A Case of Pancreatic Cancer After Heart Transplantation
- Combination Evaluation of Preoperative Risk Indices Predicts Requirement of Biventricular Assist Device
- Urgent Management of Rapid Heart Rate in Patients With Atrial Fibrillation/Flutter and Left Ventricular Dysfunction:– Comparison of the Ultra-Short-Acting β1-Selective Blocker Landiolol With Digoxin (J-Land Study) –
- Successful Conversion From Thiazide to Tolvaptan in a Patient With Stage D Heart Failure and Chronic Kidney Disease Before Heart Transplantation
- Everolimus-Incorporated Immunosuppressant Strategy Improves Renal Dysfunction While Maintaining Low Rejection Rates After Heart Transplantation in Japanese Patients
- A Case With Recovery of Response to Tolvaptan Associated With Remission of Acute Kidney Injury and Increased Urine Osmolality
- Urine Osmolality Estimated Using Urine Urea Nitrogen, Sodium and Creatinine Can Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
- Volumetric and Functional Assessment of Ventricles in Pulmonary Hypertension on 3-Dimensional Echocardiography
- Preoperative Levels of Bilirubin or Creatinine Adjusted by Age Can Predict Their Reversibility After Implantation of Left Ventricular Assist Device
- Development and Psychometric Properties of the Japanese Heart Failure Knowledge Scale:Japanese Heart Failure Knowledge Scale
- Insufficient Self-Care Is an Independent Risk Factor for Adverse Clinical Outcomes in Japanese Patients With Heart Failure
- Tolvaptan Can Improve Clinical Course in Responders:Validation Analysis for the Definition of Responsiveness by Urine Volume
- Survey of blood pump diaphragm damage in the NIPRO-ventricular assist device
- Urgent Management of Rapid Heart Rate in Patients With Atrial Fibrillation/Flutter and Left Ventricular Dysfunction : Comparison of the Ultra-Short-Acting β1-Selective Blocker Landiolol With Digoxin (J-Land Study)
- How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients?
- Trend of Clinical Outcome and Surrogate Markers During Titration of β-Bloeker in Heart Failure Patients With Reduced Ejection Fraction : Relevance of Achieved Heart Rate and β-Blocker Dose
- Novel Criteria of Urine Osmolality Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients : Association Between Non-Responders and Chronic Kidney Disease
- Urine Osmolality Estimated Using Urine Urea Nitrogen, Sodium and Creatinine Can Effectively Predict Response to Tolvaptan in Decompensated Heart Failure Patients
- Low Cardiac Output Stimulates Vasopressin Release in Patients With Stage D Heart Failure:– Its Relevance to Poor Prognosis and Reversal by Surgical Treatment –
- Increased Urine Aquaporin-2 Relative to Plasma Arginine Vasopressin Is a Novel Marker of Response to Tolvaptan in Patients With Decompensated Heart Failure
- Recipients With Shorter Cardiopulmonary Bypass Time Achieve Improvement of Parasympathetic Reinnervation Within 6 Months After Heart Transplantation